SynapDx Corp.

Device Transactions Medical device developers closed the third quarter of 2013 with $644 million in financing, a big decline compared with the previous two quarters, which each tallied both tallied ov

Start-Up Execs Abide Therapeutics Inc. Gary O’Neill, PhD To: VP, Biology (October) From: VP, & Discovery Site Head, Merck Research Laboratories Phone: 858-427-2590 Akebia Therapeutics Inc.

Start-Up Execs Adheron Therapeutics Hari Kumar, PhD To: CEO (September) From: CBO, Amira Pharmaceuticals Inc. Phone: 858-926-8155 Akebia Therapeutics Inc. John P. Butler To: Pres. & CEO (Aug

Company Changes ATRE , Ajey To: Symmetry Surgical Inc. , Pres. (August) From: Zimmer Holdings Inc., Gen. Mgr., Trabecular Metal Technologies Phone: 574-268-2252 DEGOLYER , Don To: Endo Intern